United States · FDA National Drug Code directory

Cantharis

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
0220-1092_09be97f2-2761-2ea1-e063-6394a90a17b9
Product NDC
0220-1092
Form
PELLET
Composition / generic term
LYTTA VESICATORIA
Labeler
Boiron
Marketing category
UNAPPROVED HOMEOPATHIC
Marketing start / end (source format)
19830303
Source listing expiry
20261231

Source-listed ingredients

  • LYTTA VESICATORIA — 12 [hp_C]/12[hp_C]

These values do not establish equivalence or a dose recommendation.

Packages

  • 12 [hp_C] in 1 TUBE (0220-1092-41) · 0220-1092-41

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →
Cantharis — United States | Molindra Medicines